Periodic Reporting for period 1 - RENAISSANCE (Advanced biomarker discovery for earlier diagnosis and improved prognosis of NAFLD stages via high resolution mass spectrometry.)

The RENAISSANCE project addressed a prevalent global health issue: non-alcoholic fatty liver disease (NAFLD), presently being termed as “metabolic dysfunction-associated steatotic liver disease (MASLD)”. MASLD affects approximately 25% of the adult and elderly population...